XML 41 R33.htm IDEA: XBRL DOCUMENT v3.26.3
ACCRUED EXPENSES (Tables)
9 Months Ended
Sep. 30, 2026
Payables and Accruals [Abstract]  
Summary of Accrued Expenses

The following table summarizes the Company’s accrued expenses for each of the periods indicated:

 

 

 

As of
September 30, 2026

 

 

As of
December 31, 2025

 

 

 

(in thousands)

 

Product revenue related reserves

 

$

109,098

 

 

$

117,518

 

Accrued contract manufacturing costs

 

 

58,946

 

 

 

92,281

 

Accrued employee compensation costs

 

 

45,812

 

 

 

58,607

 

Accrued litigation settlement charge

 

 

39,000

 

 

 

—

 

Accrued professional fees

 

 

22,015

 

 

 

17,840

 

Accrued clinical and pre-clinical costs

 

 

14,303

 

 

 

18,894

 

Accrued income taxes

 

 

10,217

 

 

 

4,755

 

Accrued royalties

 

 

9,427

 

 

 

10,863

 

Accrued interest expense

 

 

4,575

 

 

 

20,714

 

Accrued clinical collaboration costs

 

 

3,336

 

 

 

10,222

 

Other

 

 

5,035

 

 

 

7,965

 

Total accrued expenses

 

$

321,764

 

 

$

359,659